Avistone Biotechnology Co., Ltd.
Clinical trials sponsored by Avistone Biotechnology Co., Ltd., explained in plain language.
-
New drug targets rare gene changes in advanced cancers
Disease control Recruiting nowThis early-phase study tests a new drug called ANS03 in people with advanced solid tumors that have specific gene changes (ROS1 or NTRK). The main goals are to check safety and find the right dose. About 96 adults will take part. This is not a cure, but aims to control the diseas…
Phase: PHASE1 • Sponsor: Avistone Biotechnology Co., Ltd. • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
New hope for hard-to-treat lung cancer: targeted drug combo enters key trial
Disease control Recruiting nowThis study tests a new drug called andamertinib, alone or with chemotherapy, for people with advanced lung cancer that has certain rare gene changes (atypical EGFR mutations). About 40 participants who have not had prior treatment will be randomly assigned to receive the drug, th…
Phase: PHASE2 • Sponsor: Avistone Biotechnology Co., Ltd. • Aim: Disease control
Last updated May 13, 2026 16:03 UTC
-
New hope for hard-to-treat tumors? early trial begins
Disease control Recruiting nowThis early-phase study tests a new drug called ANS014004 in people with advanced solid tumors that have not responded to other treatments. The main goals are to check the drug's safety, find the right dose, and see if it can shrink tumors. About 63 adults with specific genetic ch…
Phase: PHASE1 • Sponsor: Avistone Biotechnology Co., Ltd. • Aim: Disease control
Last updated May 11, 2026 20:53 UTC